Reference page — cumulative record through Monday, October 19, 2026 UTC. Reference pages update as the archive grows; only dated daily editions are immutable pages of record.
Docling
Product reference — Docling by Docling-project · sector: Other. Cumulative disclosure record for this product across the archive.
Product totals
| All-time | YTD | |
|---|---|---|
| CVEs | 16 | 16 |
| KEV entries | 0 | 0 |
| KEV/100 | Med CVSS | Med EPSS | C | H | M | L |
|---|---|---|---|---|---|---|
| 0.0 | 7.0 | .0025 | 0 | 8 | 8 | 0 |
KEV/100 = KEV entries ÷ CVEs × 100. Med CVSS / Med EPSS are medians over this product's disclosures. C/H/M/L = disclosures by CVSS severity band.
Monthly disclosures
Trend (by first-seen month, full archive): ▅▁▁▁█
| Month | New CVEs |
|---|---|
| 2026-06 | 6 |
| 2026-07 | 0 |
| 2026-08 | 0 |
| 2026-09 | 0 |
| 2026-10 | 10 |
Notable CVEs
Ranked by the published formula: KEV → EPSS → CVSS → CVE ID.
| CVE | CVSS | EPSS %ile | Severity | KEV | First seen |
|---|---|---|---|---|---|
| CVE-2026-44017 | 7.5 | 52.4 | HIGH | — | 2026-06-24 |
| CVE-2026-44020 | 7.5 | 47.7 | HIGH | — | 2026-06-24 |
| CVE-2026-44016 | 8.2 | 47.3 | HIGH | — | 2026-06-24 |
| CVE-2026-105751 | 6.9 | 30.4 | MEDIUM | — | 2026-10-05 |
| CVE-2026-47214 | 7.1 | 29.7 | HIGH | — | 2026-06-26 |
| CVE-2026-105744 | 8.8 | 26.4 | HIGH | — | 2026-10-05 |
| CVE-2026-105750 | 7.5 | 21.4 | HIGH | — | 2026-10-05 |
| CVE-2026-105749 | 6.5 | 17.3 | MEDIUM | — | 2026-10-05 |
| CVE-2026-105747 | 4.3 | 12.9 | MEDIUM | — | 2026-10-05 |
| CVE-2026-105742 | 5.3 | 12.4 | MEDIUM | — | 2026-10-05 |
| CVE-2026-105746 | 5.3 | 12.0 | MEDIUM | — | 2026-10-05 |
| CVE-2026-105748 | 4.3 | 11.8 | MEDIUM | — | 2026-10-05 |
| CVE-2026-44022 | 5.5 | 10.1 | MEDIUM | — | 2026-06-24 |
| CVE-2026-105743 | 5.8 | 8.1 | MEDIUM | — | 2026-10-05 |
| CVE-2026-44018 | 7.1 | 4.9 | HIGH | — | 2026-06-26 |
Recent CVEs
| CVE | CVSS | EPSS %ile | Severity | KEV | First seen |
|---|---|---|---|---|---|
| CVE-2026-105743 | 5.8 | 8.1 | MEDIUM | — | 2026-10-05 |
| CVE-2026-105749 | 6.5 | 17.3 | MEDIUM | — | 2026-10-05 |
| CVE-2026-105742 | 5.3 | 12.4 | MEDIUM | — | 2026-10-05 |
| CVE-2026-105748 | 4.3 | 11.8 | MEDIUM | — | 2026-10-05 |
| CVE-2026-105747 | 4.3 | 12.9 | MEDIUM | — | 2026-10-05 |
| CVE-2026-105745 | 7.8 | 1.7 | HIGH | — | 2026-10-05 |
| CVE-2026-105751 | 6.9 | 30.4 | MEDIUM | — | 2026-10-05 |
| CVE-2026-105746 | 5.3 | 12.0 | MEDIUM | — | 2026-10-05 |
| CVE-2026-105744 | 8.8 | 26.4 | HIGH | — | 2026-10-05 |
| CVE-2026-105750 | 7.5 | 21.4 | HIGH | — | 2026-10-05 |
| CVE-2026-47214 | 7.1 | 29.7 | HIGH | — | 2026-06-26 |
| CVE-2026-44018 | 7.1 | 4.9 | HIGH | — | 2026-06-26 |
| CVE-2026-44020 | 7.5 | 47.7 | HIGH | — | 2026-06-24 |
| CVE-2026-44017 | 7.5 | 52.4 | HIGH | — | 2026-06-24 |
| CVE-2026-44022 | 5.5 | 10.1 | MEDIUM | — | 2026-06-24 |
KEV entries
No entries in the CISA KEV catalog.
Related
Vendor: Docling-project — all products and the full vendor record.
Methodology
A product is a (vendor, product) pair as named in the affected-product data. Rate statistics are arithmetic over published figures. Counts key to first-seen day. Raw counts are not comparable across products; this is a reference page assembled from the public record, not a ranking by our judgment.
Sources. CVE Program (cvelistV5), NVD (NIST), CISA KEV, FIRST EPSS.
